Literature DB >> 7717225

Percutaneous ablation therapy for hepatocellular carcinomas.

H B D'Agostino1, A Solinas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7717225     DOI： 10.2214/ajr.164.5.7717225

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN： 0361-803X            Impact factor:   3.959


× No keyword cloud information.
  3 in total

1.  Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size.

Authors:  E J Patterson; C H Scudamore; D A Owen; A G Nagy; A K Buczkowski
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

2.  [Present state of radio frequency ablation of liver tumors in Germany].

Authors:  M Birth; P Hildebrand; G Dahmen; A Ziegler; D C Bröring; C Hillert; H P Bruch
Journal:  Chirurg       Date:  2004-04       Impact factor: 0.955

3.  Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma.

Authors:  Chung-Bao Hsieh; Hao-Ming Chang; Teng-Wei Chen; Chung-Jueng Chen; De-Chuan Chan; Jyh-Cherng Yu; Yao-Chi Liu; Tzu-Ming Chang; Kuo-Liang Shen
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.